136 related articles for article (PubMed ID: 35901496)
21. Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
Boonpawa R; Moradi N; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2015 Dec; 98(4):690-702. PubMed ID: 26441251
[TBL] [Abstract][Full Text] [Related]
22. An open source physiologically based kinetic model for the chicken (Gallus gallus domesticus): Calibration and validation for the prediction residues in tissues and eggs.
Lautz LS; Nebbia C; Hoeks S; Oldenkamp R; Hendriks AJ; Ragas AMJ; Dorne JLCM
Environ Int; 2020 Mar; 136():105488. PubMed ID: 31991240
[TBL] [Abstract][Full Text] [Related]
23. A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.
Baier V; Paini A; Schaller S; Scanes CG; Bone AJ; Ebeling M; Preuss TG; Witt J; Heckmann D
Environ Int; 2022 Nov; 169():107547. PubMed ID: 36179644
[TBL] [Abstract][Full Text] [Related]
24. Performance evaluation of the GastroPlus
Zhang F; Bartels M; Clark A; Erskine T; Auernhammer T; Bhhatarai B; Wilson D; Marty S
SAR QSAR Environ Res; 2018 Nov; 29(11):875-893. PubMed ID: 30286617
[TBL] [Abstract][Full Text] [Related]
25. ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.
Li H; Bunglawala F; Hewitt NJ; Pendlington R; Cubberley R; Nicol B; Spriggs S; Baltazar M; Cable S; Dent M
Toxicol Sci; 2023 Oct; 196(1):1-15. PubMed ID: 37584694
[TBL] [Abstract][Full Text] [Related]
26. In vitro-based prediction of human plasma concentrations of food-related compounds.
Kitaguchi T; Ito M; Ohno K; Ota N; Kobayashi K; Sato H; Iwao T; Matsunaga T; Tanaka M; Hisaka A
ALTEX; 2023; 40(4):595-605. PubMed ID: 37216287
[TBL] [Abstract][Full Text] [Related]
27. Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerations.
Li H; Yuan H; Middleton A; Li J; Nicol B; Carmichael P; Guo J; Peng S; Zhang Q
Toxicol In Vitro; 2021 Aug; 74():105171. PubMed ID: 33848589
[TBL] [Abstract][Full Text] [Related]
28. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
Francis LJ; Houston JB; Hallifax D
Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
[TBL] [Abstract][Full Text] [Related]
29. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.
Paini A; Leonard JA; Joossens E; Bessems JGM; Desalegn A; Dorne JL; Gosling JP; Heringa MB; Klaric M; Kliment T; Kramer NI; Loizou G; Louisse J; Lumen A; Madden JC; Patterson EA; Proença S; Punt A; Setzer RW; Suciu N; Troutman J; Yoon M; Worth A; Tan YM
Comput Toxicol; 2019 Feb; 9():61-72. PubMed ID: 31008414
[TBL] [Abstract][Full Text] [Related]
30. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
[TBL] [Abstract][Full Text] [Related]
31. Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.
Zhang M; van Ravenzwaay B; Fabian E; Rietjens IMCM; Louisse J
Arch Toxicol; 2018 Mar; 92(3):1075-1088. PubMed ID: 29234833
[TBL] [Abstract][Full Text] [Related]
32. PBK Model-Based Prediction of Intestinal Microbial and Host Metabolism of Zearalenone and Consequences for its Estrogenicity.
Mendez-Catala DM; Wang Q; Rietjens IMCM
Mol Nutr Food Res; 2021 Dec; 65(23):e2100443. PubMed ID: 34648686
[TBL] [Abstract][Full Text] [Related]
33. In vitro-in silico-based prediction of inter-individual and inter-ethnic variations in the dose-dependent cardiotoxicity of R- and S-methadone in humans.
Shi M; Dong Y; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2022 Aug; 96(8):2361-2380. PubMed ID: 35604418
[TBL] [Abstract][Full Text] [Related]
34. The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine.
Bessems JGM; Paini A; Gajewska M; Worth A
Toxicology; 2017 Dec; 392():119-129. PubMed ID: 28288858
[TBL] [Abstract][Full Text] [Related]
35. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
Boonpawa R; Spenkelink A; Rietjens IM; Punt A
Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179
[TBL] [Abstract][Full Text] [Related]
36. Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans.
Geci R; Gadaleta D; de Lomana MG; Ortega-Vallbona R; Colombo E; Serrano-Candelas E; Paini A; Kuepfer L; Schaller S
Arch Toxicol; 2024 May; ():. PubMed ID: 38722347
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
[TBL] [Abstract][Full Text] [Related]
38. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
[TBL] [Abstract][Full Text] [Related]
39. A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals.
Wang J; Nolte TM; Owen SF; Beaudouin R; Hendriks AJ; Ragas AMJ
Environ Sci Technol; 2022 May; 56(10):6500-6510. PubMed ID: 35472258
[TBL] [Abstract][Full Text] [Related]
40. Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications.
Paini A; Leonard JA; Kliment T; Tan YM; Worth A
Regul Toxicol Pharmacol; 2017 Nov; 90():104-115. PubMed ID: 28866268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
